Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
diagnosis
|
| gptkbp:advantage |
direct detection from blood without culture
|
| gptkbp:detects |
gptkb:Candida_albicans
gptkb:Candida_glabrata gptkb:Candida_krusei gptkb:Candida_parapsilosis gptkb:Candida_tropicalis gptkb:Candida_species |
| gptkbp:developedBy |
gptkb:T2_Biosystems
|
| https://www.w3.org/2000/01/rdf-schema#label |
T2Candida Panel
|
| gptkbp:intendedUse |
hospitalized patients at risk for candidemia
|
| gptkbp:marketedIn |
gptkb:Europe
gptkb:United_States |
| gptkbp:method |
molecular diagnostic
|
| gptkbp:regulates |
FDA cleared
|
| gptkbp:sensitivity |
high
|
| gptkbp:specificity |
high
|
| gptkbp:technology |
gptkb:T2_Magnetic_Resonance_(T2MR)
|
| gptkbp:turnaroundTime |
3-5 hours
|
| gptkbp:type |
whole blood
|
| gptkbp:usedFor |
diagnosis of invasive candidiasis
|
| gptkbp:bfsParent |
gptkb:T2_Biosystems
|
| gptkbp:bfsLayer |
6
|